Clinical Scorecard: Can Risk Infographic Encourage Smoking Cessation in Patients With COPD?
At a Glance
| Category | Detail |
|---|---|
| Condition | Chronic Obstructive Pulmonary Disease (COPD) |
| Key Mechanisms | Personalized biomedical risk assessment infographic based on spirometry data. |
| Target Population | Current smokers with COPD referred for spirometry. |
| Care Setting | Single center, pulmonary function laboratory. |
Key Highlights
- Infographic increased smoking cessation counseling from 67% to 81% of eligible visits.
- Recommendations or prescriptions for smoking cessation pharmacotherapy rose from 12% to 18%.
- Physicians found the infographic intuitive and useful for smoking cessation discussions.
- Implementation fidelity was limited, with the infographic delivered in only 50% of eligible visits.
- Study design limitations include lack of a concurrent control group and smaller sample size.
Guideline-Based Recommendations
Diagnosis
- Assess COPD severity and smoking status using spirometry.
Management
- Utilize personalized risk assessment tools to enhance smoking cessation counseling.
Monitoring & Follow-up
- Track smoking cessation counseling rates and pharmacotherapy recommendations.
Risks
- Consider potential temporal confounding in behavioral change observations.
Patient & Prescribing Data
Patients with COPD who smoke.
Increased frequency of new respiratory medication prescriptions during the intervention.
Clinical Best Practices
- Incorporate personalized risk assessment tools in smoking cessation strategies.
- Ensure consistent delivery of smoking cessation resources to eligible patients.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
